NanoViricides
NNVC
#10132
Rank
A$33.5 M
Marketcap
A$1.86
Share price
0.82%
Change (1 day)
-17.75%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$1.97 Million

According to NanoViricides's latest financial reports the company's total liabilities are A$1.97 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30A$2.03 M-33.3%
2023-06-30A$3.05 M410%
2022-06-30A$0.59 M27.8%
2021-06-30A$0.46 M-85.01%
2020-06-30A$3.12 M-22.96%
2019-06-30A$4.05 M240.4%
2018-06-30A$1.19 M-86.31%
2017-06-30A$8.7 M-52.29%
2016-06-30A$18.23 M13.15%
2015-06-30A$16.11 M-25.83%
2014-06-30A$21.73 M136.22%
2013-06-30A$9.19 M429.44%
2012-06-30A$1.73 M217.16%
2011-06-30A$0.54 M-81.24%
2010-06-30A$2.92 M358.12%
2009-06-30A$0.63 M-40.49%
2008-06-30A$1.07 M6.73%
2007-06-30A$1 M-50.21%
2006-06-30A$2.01 M2230.53%
2005-06-30A$0.08 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioCryst Pharmaceuticals
BCRX
A$1.26 B 63,757.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$2.02 B 102,199.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$56.12 B 2,837,744.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$118.50 B 5,992,077.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$117.52 B 5,942,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$92.76 B 4,690,559.16%๐Ÿ‡ฌ๐Ÿ‡ง UK